SRPT
Sarepta Therapeutics, Inc. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website arepta.com
- Employees(FY) 1162
- ISIN US8036071004
Performance
1W
1M
3M
6M
YTD
1Y
Profile
Investment Analysis Report: SRPT
Overview
In this investment analysis report, we will delve into the financial statements of SRPT, a company in the Health Technology sector specializing in Pharmaceuticals. We will analyze the company's valuation, financial health, earnings and revenue growth, profitability, operating margin, operating cash flow,...
Technical Analysis of SRPT 2024-07-18
Overview
The recent trading activity of SRPT (Sarepta Therapeutics, Inc.) indicates a significant downward trend over the last five trading days, characterized by declining prices and weakening momentum. This analysis will delve into the technical indicators across various categories—trend, momentum, volatility, and volume—to provide a comprehen...
Recent News & Updates
- 2024-07-23 20:00
SRPT: Rating decreased to a SELL(Argus Research)
- 2024-07-21 06:59
- 2024-07-19 09:55
- 2024-07-17 08:00
- 2024-07-16 20:00
SRPT: Raising target price to $156.00(Argus Research)
- 2024-07-16 20:00
- 2024-07-16 12:00
- 2024-07-16 00:00
- 2024-07-09 20:00
SRPT: Rating increased to a HOLD(Argus Research)
- 2024-07-08 12:04
- 2024-07-08 00:04
- 2024-07-06 08:00
- 2024-07-04 06:35
- 2024-07-03 10:05
1 Soaring Growth Stock to Buy and Hold for 10 Years(Motley Fool)
- 2024-07-03 10:00
- 2024-07-02 20:00
SRPT: Rating decreased to a SELL(Argus Research)
- 2024-06-28 18:30
- 2024-06-28 06:30
- 2024-06-27 13:28
- 2024-06-26 10:06
- 2024-06-26 07:15
- 2024-06-26 06:10
- 2024-06-26 03:45
- 2024-06-24 14:55
Sarepta Therapeutics Scores 90-Plus RS Rating On Muscular Dystrophy Approval(Investor's Business Daily)
- 2024-06-24 12:40
- 2024-06-24 11:30
- 2024-06-24 08:08
- 2024-06-24 04:54
- 2024-06-24 03:49
- 2024-06-23 15:49